267 related articles for article (PubMed ID: 24523058)
1. In vivo near-infrared fluorescence targeting of T cells: comparison of nanobodies and conventional monoclonal antibodies.
Bannas P; Well L; Lenz A; Rissiek B; Haag F; Schmid J; Hochgräfe K; Trepel M; Adam G; Ittrich H; Koch-Nolte F
Contrast Media Mol Imaging; 2014; 9(2):135-42. PubMed ID: 24523058
[TBL] [Abstract][Full Text] [Related]
2. Molecular imaging of tumors with nanobodies and antibodies: Timing and dosage are crucial factors for improved in vivo detection.
Bannas P; Lenz A; Kunick V; Well L; Fumey W; Rissiek B; Haag F; Schmid J; Schütze K; Eichhoff A; Trepel M; Adam G; Ittrich H; Koch-Nolte F
Contrast Media Mol Imaging; 2015; 10(5):367-78. PubMed ID: 25925493
[TBL] [Abstract][Full Text] [Related]
3. Validation of nanobody and antibody based in vivo tumor xenograft NIRF-imaging experiments in mice using ex vivo flow cytometry and microscopy.
Bannas P; Lenz A; Kunick V; Fumey W; Rissiek B; Schmid J; Haag F; Leingärtner A; Trepel M; Adam G; Koch-Nolte F
J Vis Exp; 2015 Apr; (98):e52462. PubMed ID: 25867711
[TBL] [Abstract][Full Text] [Related]
4. Quantitative magnetic resonance imaging of enzyme activity on the cell surface: in vitro and in vivo monitoring of ADP-ribosyltransferase 2 on T cells.
Bannas P; Graumann O; Balcerak P; Peldschus K; Kaul MG; Hohenberg H; Haag F; Adam G; Ittrich H; Koch-Nolte F
Mol Imaging; 2010 Aug; 9(4):211-22. PubMed ID: 20643024
[TBL] [Abstract][Full Text] [Related]
5. A new monoclonal antibody detects a developmentally regulated mouse ecto-ADP-ribosyltransferase on T cells: subset distribution, inbred strain variation, and modulation upon T cell activation.
Koch-Nolte F; Duffy T; Nissen M; Kahl S; Killeen N; Ablamunits V; Haag F; Leiter EH
J Immunol; 1999 Dec; 163(11):6014-22. PubMed ID: 10570289
[TBL] [Abstract][Full Text] [Related]
6. Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics.
Bannas P; Hambach J; Koch-Nolte F
Front Immunol; 2017; 8():1603. PubMed ID: 29213270
[TBL] [Abstract][Full Text] [Related]
7. Effect of Dye and Conjugation Chemistry on the Biodistribution Profile of Near-Infrared-Labeled Nanobodies as Tracers for Image-Guided Surgery.
Debie P; Van Quathem J; Hansen I; Bala G; Massa S; Devoogdt N; Xavier C; Hernot S
Mol Pharm; 2017 Apr; 14(4):1145-1153. PubMed ID: 28245129
[TBL] [Abstract][Full Text] [Related]
8. Single domain antibodies from llama effectively and specifically block T cell ecto-ADP-ribosyltransferase ART2.2 in vivo.
Koch-Nolte F; Reyelt J; Schössow B; Schwarz N; Scheuplein F; Rothenburg S; Haag F; Alzogaray V; Cauerhff A; Goldbaum FA
FASEB J; 2007 Nov; 21(13):3490-8. PubMed ID: 17575259
[TBL] [Abstract][Full Text] [Related]
9. Homogeneous tumor targeting with a single dose of HER2-targeted albumin-binding domain-fused nanobody-drug conjugates results in long-lasting tumor remission in mice.
Xenaki KT; Dorrestijn B; Muns JA; Adamzek K; Doulkeridou S; Houthoff H; Oliveira S; van Bergen En Henegouwen PM
Theranostics; 2021; 11(11):5525-5538. PubMed ID: 33859761
[No Abstract] [Full Text] [Related]
10. In vitro analysis and in vivo tumor targeting of a humanized, grafted nanobody in mice using pinhole SPECT/micro-CT.
Vaneycken I; Govaert J; Vincke C; Caveliers V; Lahoutte T; De Baetselier P; Raes G; Bossuyt A; Muyldermans S; Devoogdt N
J Nucl Med; 2010 Jul; 51(7):1099-106. PubMed ID: 20554727
[TBL] [Abstract][Full Text] [Related]
11. Generation and characterization of ecto-ADP-ribosyltransferase ART2.1/ART2.2-deficient mice.
Ohlrogge W; Haag F; Löhler J; Seman M; Littman DR; Killeen N; Koch-Nolte F
Mol Cell Biol; 2002 Nov; 22(21):7535-42. PubMed ID: 12370300
[TBL] [Abstract][Full Text] [Related]
12. Tumor-specific near-infrared nanobody probe rapidly labels tumors in an orthotopic mouse model of pancreatic cancer.
Lwin TM; Hernot S; Hollandsworth H; Amirfakhri S; Filemoni F; Debie P; Hoffman RM; Bouvet M
Surgery; 2020 Jul; 168(1):85-91. PubMed ID: 32370916
[TBL] [Abstract][Full Text] [Related]
13. A recombinant heavy chain antibody approach blocks ART2 mediated deletion of an iNKT cell population that upon activation inhibits autoimmune diabetes.
Scheuplein F; Rissiek B; Driver JP; Chen YG; Koch-Nolte F; Serreze DV
J Autoimmun; 2010 Mar; 34(2):145-54. PubMed ID: 19796917
[TBL] [Abstract][Full Text] [Related]
14. Characterization of multiple alleles of the T-cell differentiation marker ART2 (RT6) in inbred and wild rats.
Rothenburg S; Haag F; Koch-Nolte F; Carter C; Graham M; Butcher GW
Immunogenetics; 2005 Nov; 57(10):739-49. PubMed ID: 16195877
[TBL] [Abstract][Full Text] [Related]
15. Transgenic overexpression of toxin-related ecto-ADP-ribosyltransferase ART2.2 sensitizes T cells but not B cells to NAD-induced cell death.
Bannas P; Scheuplein F; Well L; Hermans-Borgmeyer I; Haag F; Koch-Nolte F
Mol Immunol; 2011 Sep; 48(15-16):1762-70. PubMed ID: 21641039
[TBL] [Abstract][Full Text] [Related]
16. Changing patterns of cell surface mono (ADP-ribosyl) transferase antigen ART2.2 on resting versus cytopathically-activated T cells in NOD/Lt mice.
Ablamunits V; Bridgett M; Duffy T; Haag F; Nissen M; Koch-Nolte F; Leiter H
Diabetologia; 2001 Jul; 44(7):848-58. PubMed ID: 11508269
[TBL] [Abstract][Full Text] [Related]
17. NAD+ released during inflammation participates in T cell homeostasis by inducing ART2-mediated death of naive T cells in vivo.
Adriouch S; Hubert S; Pechberty S; Koch-Nolte F; Haag F; Seman M
J Immunol; 2007 Jul; 179(1):186-94. PubMed ID: 17579037
[TBL] [Abstract][Full Text] [Related]
18. Development and evaluation of nanobody tracers for noninvasive nuclear imaging of the immune-checkpoint TIGIT.
Zeven K; De Groof TWM; Ceuppens H; Awad RM; Ertveldt T; de Mey W; Meeus F; Raes G; Breckpot K; Devoogdt N
Front Immunol; 2023; 14():1268900. PubMed ID: 37799715
[TBL] [Abstract][Full Text] [Related]
19. Comparison of mAbs targeting epithelial cell adhesion molecule for the detection of prostate cancer lymph node metastases with multimodal contrast agents: quantitative small-animal PET/CT and NIRF.
Hall MA; Pinkston KL; Wilganowski N; Robinson H; Ghosh P; Azhdarinia A; Vazquez-Arreguin K; Kolonin AM; Harvey BR; Sevick-Muraca EM
J Nucl Med; 2012 Sep; 53(9):1427-37. PubMed ID: 22872743
[TBL] [Abstract][Full Text] [Related]
20. Production and Characterization of Novel Camel Single Domain Antibody Targeting Mouse Vascular Endothelial Growth Factor.
Kazemi-Lomedasht F; Behdani M; Habibi-Anbouhi M; Shahbazzadeh D
Monoclon Antib Immunodiagn Immunother; 2016 Jun; 35(3):167-71. PubMed ID: 27167350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
